Alex Moore is a partner practising in the areas of mergers and acquisitions, corporate finance, securities law and corporate/commercial law.  He has extensive experience in public company M&A, private equity, proxy contests and contested transactions.
 
Alex has recently represented BCE in its pending $52 billion acquisition by a private equity consortium that includes Teachers Private Capital, the private investment arm of the Ontario Teachers Pension Plan, Providence Equity Partners Inc., and Madison Dearborn Partners LLC.  Alex also played a significant role advising BCE in the litigation brought by certain bondholders of Bell Canada (BCE's main subsidiary) in opposition to the transaction.  That litigation was ultimately favourably resolved for BCE at the Supreme Court of Canada in June 2008.
 
In 2007 Alex represented the majority shareholders of Husky Injection Molding in the $1 billion sale of the company to Onex Partners.

Alex represented Xstrata Plc's in its successful $24.1 billion acquisition of Falconbridge Limited in August 2006.  The transaction ranks as the largest unsolicited take-over bid in Canadian history.  Earlier in 2006, Alex represented Scion Capital in its dissident proxy battle in opposition to the $450 million acquisition of Bolivar Gold Corp. by Gold Fields Limited and related litigation before the courts of Ontario and the Yukon Territory.

Alex also has extensive experience in private company acquisitions and has represented some of Canada's largest private equity firms and their portfolio companies in both acquisitions and acquisition financings.  He represented EdgeStone Capital Partners in its acquisition of an interest in an international group of companies based in Houston, Texas that supplies metal goods to oil and gas fields in Canada, the United States and the North Sea.
 
Financing transactions in which Alex has been involved include the US$195 million Rule 144A/Regulation S offering of convertible notes by Digital River, Inc., a US$42 million offering of common shares by Pharmacyclics, Inc., a US$53 million offering of common shares by Dyax, Inc., and a series of common shares offerings by La Jolla Pharmaceutical Company, Inc.  Alex has also advised start-up companies and their investors on venture capital financings.

Alex received his B.Sc. (Eng.) in Electrical Engineering from Queen's University in 1993 and his LL.B. from the University of Toronto in 1996.   Alex joined Davies as a partner in 2005.  He was previously a partner with a leading law firm in San Francisco, California.

Top of Page